APGE vs SOFI · $2.34B cap vs P/E 39, rev $283.1M
Apogee Therapeutics, Inc. Common Stock (APGE) versus SoFi Technologies Inc. (SOFI) — a side-by-side from cached financials, not a winner call.
Apogee Therapeutics, Inc. Common Stock (APGE) is a biotechnology company listed on US.
SoFi Technologies Inc. (SOFI) is a credit services company listed on NASDAQ.
APGE does not have a complete income-statement cache yet.
Latest reported SOFI revenue for 2026-06-30 was $283.1M. Net income was $323.3M. SOFI currently screens at market cap $22.25B and trailing P/E 38.5.
APGE currently screens at market cap $2.34B. SOFI currently screens at market cap $22.25B and trailing P/E 38.5.
Not investment advice. Open the APGE and SOFI stock pages for the full models.
Not investment advice.